Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,759,528
+$3,369,770 QoQ
Shares Held
480,762
+68.6% QoQ
Ownership
0.728%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 163 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Derivatives in RGNX
reported options exposure · as of Sep 30, 2025CallValue
$205,545
CallShares
21,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. RGNX ranks #156 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RGNX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,759,528 | 480,762 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,389,758 | 285,174 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,091,190 | 214,666 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $205,545 | 21,300 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $836,259 | 86,659 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $919,101 | 111,949 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,379,727 | 332,829 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,221,719 | 1,322,344 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,739,536 | 261,157 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,585,897 | 306,487 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,493,848 | 165,821 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $993,047 | 55,323 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,320,344 | 201,722 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,084,816 | 204,343 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,600,280 | 719,211 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $495,149 | 21,832 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $450,446 | 17,043 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $7,245,908 | 218,316 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $935,645 | 28,613 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $258,730 | 6,172 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,580,683 | 195,127 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,245,680 | 212,421 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $666,156 | 14,686 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $680,400 | 15,000 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $384,454 | 13,970 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,684,489 | 154,344 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||